Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 2852-2860

  Waris, Matti E ^a,c   Tsou, Cecilia ^a   Erdman, Dean D ^a   Zaki, Sherif R ^a   Anderson, Larry J ^a,b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 5; LIVE VACCINE; MESSENGER RNA; RESPIRATORY SYNCYTIAL VIRUS VACCINE; CYTOKINE; FORMALDEHYDE; INACTIVATED VACCINE; INTERLEUKIN DERIVATIVE; PRIMER DNA; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; IMMUNOPATHOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS IMMUNITY; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS INFECTIVITY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; CYTOLOGY; IMMUNOLOGY; INFLAMMATION; ISOLATION AND PURIFICATION; LEUKOCYTE COUNT; LUNG; LUNG LAVAGE; LYMPHOCYTE COUNT; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TH2 CELL; VIROLOGY; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; CD4 LYMPHOCYTE COUNT; CYTOKINES; DNA PRIMERS; FORMALDEHYDE; INFLAMMATION; INTERLEUKINS; LEUKOCYTE COUNT; LUNG; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER; TH2 CELLS; VACCINES, INACTIVATED; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0029664574     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.2852-2860.1996     Document Type: Article

References (43)

1. Alwan, W. H., W. J. Kozlowska. and P. J. M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89
2. Anderson, L. J.. J. C. Hierholzer. P. G. Bingham, and Y. O. Stone. 1985. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay J Clin. Microbiol. 22:1050-1052.
3. Anderson, L. J., C. Tsou, C. Potter, H. L. Keyscrling, T. F. Smith, G. Ananaba, and C. R. M. Bangham. 1994. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J. Intect. Dis, 170:1201-1208.
4. Brown, K. D., S. M. Zurawski. T. R. Mosmann, and G. R. Zurawski 1989. A family of small mducible proteins secreted by members of new superfamily that includes leukocyte fibroblast-derived inflammatory agents, growth factors, indicators of various activation processes. J Immunol 142:679-687
5. Buser, F., and B. Montagnon. 1970. Severe illness in children exposed to natural measles after prior vaccination against the disease. Scand. J. Infect, Dis. 2:157-160.
6. Chin, J., R. L. Magoffin, L. A. Shearer, J. H. Schieble, and E. H. Lennette. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 89: 449-463.
7. Connors, M., N. A. Giese, A. B. Kulkarni. C. Y. Firestone, H. C. Morse III, and B. R. Murphy. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inacnvated RSV-immunized BALB.c mice is abrogated by depletion of interleukm-4 (IL-4) and IL-10. J. Virol 68:5321-5325.
8. Connors, M., A. B. Kulkarni, C.-Y. Firestone, K. L. Holmes, H. C. Morse III, A. V. Sotnikov, and B. R. Murphy. 1992 Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4 cells. J. Virol 66:7444-7451
9. Dubucquoi, S., P. Desreumaux. S. Janin, O. Klein, M. Goldman, J. Tav-ernier, A. Capron, and M. Capron, 1994. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion J. Exp. Med. 179:703-708.
10. Edwards. K. M.. W. D. Dupont, M K. Westrich, W. D. Plummer. Jr., P. S. Palmer, and P. F. Wright. 1994. A randomized controlled trial of coldadapled and inactivated vaccines for the prevention of influenza A disease. J. Infect. Dis. 169:68-76.
11. Erdman, D. D., and L. J. Anderson. 1990. Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA. and IgM antibodies to respirator) syncytial virus. J. Clin. Microbiol. 28: 2744-27477
12. 4.. Virology 106:141-144.
13. Fulginiti, V. A., J. J. Eller, O. F. Sieber, J. W. Joyner, M. Minamitani, and G. Meiklejohn, 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines: an aqueous trivalent arainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
14. Graham, B. S_ G. S. Henderson. Y.-W. Tang, X. Lu, K. M. Neuzil, and D. G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus J. Immunol. 151:2032-2040.
15. Graham, B. S., M. D. Perkins, P. F. Wright, and D. T. Karzon. 1988. Primary respirator) syncytial virus infection in mice. J. Med. Virol. 26:153-162.
16. Gruber, W. C., L H. Taber. W. P. Glezen, R. D. Clover, T. D. Abell. R. W. Demmler, and R. B. Couch. 1990 Live attenuated and inactivated influenza vaccine in school-age children. Am J. Dis. Child. 144:595-600.
17. Hayes, P. J., R. Scott, and J. Wheeler. 1994. In vivo production of tumor necrosis factor-α and interleukm-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virus. J. Med. Virol. 42:323-329.
18. Hildreth. S. W., R. R. Baggs, D. G. Brownstein, W. L. Castelman, and P. R. Paradiso. 1993. Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization. Vaccine 11: 615-618
19. Kapikian, A. Z., R. H. Mitchell, R. M. Chanock, R. A. Shredoff, and C. E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine Am. J. EpidemioL 89:405-421.
20. Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chancock, K. Jensen, and R. H. Parrot. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine Am. J. Epidemiol. 89: 422-433.
21. Kim, J. M_, C. L Brannan. N. G. Copeland, N. A. Jenkins, and K. W. Moore. 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes J. Immunol 148:3618-3623.
22. Kimpen. J. L., G. A. Rich, C. K. Mohar, and P. L. Ogra. 1992. Mucosal T cell distribution during infection with respiratory syncytial virus. J Med. Virol. 36:172-179.
23. Montgomery, R. A., and M. J. Dallman. 1991. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction (PCR). J Immunol. 147:554-560.
24. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone 1. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 136:2348-2357.
25. Murphy, B. R., A. V. Sotnikov, L. A. Lawrence, S. M. Banks, and G. A. Prince. 1990. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respirator) syncytial virus (RSV) or purified F-glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 8:497-502.
26. Oliveira. D. A., B. P. Holloway, E. L. Durigon, W. E. Collins, and A. A. Lal. 1995 Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria parasite. Am. J. Trop. Med. Hyg. 52:139-143.
27. Openshaw, P. J. M. 1989. Flow cytometric analysis of pulmonary lymphocvtes from mice infected with respiratory syncuial virus. Clin. Exp. Immunol. 75:324-328
28. Openshaw, P. J. M. 1991. Pulmonary epithelial T cells induced by viral infection express T cell receptors αβ. Eur. J. Immunol. 21:803-806.
29. Openshaw, P. J. M., S. L. Clarke, and F. M. Record. 1991 Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol 4:493- 500.
30. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241-251.
31. Piedra, P. A., P. R. Wyde. W. L. Castelman, M. W. Ambrose. A. M. Jewell, D. J. Speelman, and S. W. Hildreth. 1993. Enhanced pulmonary pathology associated with the use of formalin-inactivated respirator) syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine 11:1415-1419.
32. Prince, G. A., A. B. Jenson, V. G. Hemming, B. R. Murphy, E. E. Walsh, R. L. Horswood, and R. M. Chanock. 1986. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J. Virol. 57:721-728.
33. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, P. M. Quinn, C. M. Dwayer, W. McComas, P. C. Familltti, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12 J. Immunol. 148:3433-3490.
34. Sparrevolin, S., and H. R. Wulff. 1967. The nuclear segmentation of eosinophils under normal and pathological conditions. Acta Haematol. 37:120-125.
35. Tang, Y.-W., and B. S. Graham. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94:1953-1958.
36. Tang, Y.-W., and B. S. Graham. 1995. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogeniciry. J. Infect. Dis. 172:734-738.
37. Taylor, G., E. J. Stott, and A. P. Collins. 1984. Respiratory syncytial virus infection in mice. Infect. Immun. 43:649-655.
38. Trinchieri, G. 1994, lnterleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-1026
39. Vaux-Peretz. F., J.-M. Chapsal, and B. Meignier. 1992. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F. G, and N proteins and cell lysate to enhance pulmonary changes in Balbjc mice. Vaccine 10:113-116.
40. Wang, A. M., and D. F. Mark. 1990 Quantitative PCR, p 70-75 In M. A. Innis. D H Gelfand, J. S. Sninsky. and T. J. White (ed.), PCR protocols. Academic Press. Inc.. San Diego, Calif.
41. Waris, M., P. Halonen, O. Meurman. M. Mufson. and O. Ruuskanen. 1992. Shedding of infectious virus and virus antigen during acute respirator) syncytial virus infection. J. Med Virol. 38:111-116.
42. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miora, N. Harada, A. Tominagra, and K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of munne eosinophil precursors. J. Exp. Med. 167:43-56.
43. Yolken, R. H., and R. Viscidi. 1989. Enzyme immunoassay and radiotmmunoassav. p. 157-178. In N. J. Schmidt and R. W. Emmons (ed.). Diagnostic procedures for viral, rickettsial and chlamydial infections. American Public Health Association, Inc., Washington, D C.